Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mesenchymal stem cell therapy in hypertrophic and keloid scars

2 Jan 2021

Abstract excerpt

Scars are the normal outcome of wound repair and involve a co-ordinated inflammatory and fibrotic process. When a scar does not resolve, uncontrolled chronic inflammation can persist and elicits excessive scarring that leads to a range of abnormal phenotypes such as hypertrophic and keloid scars. These pathologies result in significant impairment of quality of life over a long period of time. Existing treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dermatologic Treatments and Research
Share to Wound Healing and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33386995
DOI: 10.1007/s00441-020-03361-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mesenchymal stem cell therapy in hypertrophic and keloid scarsPMID 33386995Read ↗

Keloid scarring: bench and bedside.Semantic proximity Read ↗

Recent Advances in Wound Healing, Tissue Repair, Regeneration and Scar ManagementSemantic proximity Read ↗

Adipose-derived Mesenchymal Stem Cells can Alleviate Hypertrophic Scars and Affect the Biological Activity and Oxidative Stress-related Factors of Hypertrophic Scar FibroblastsSemantic proximity Read ↗

The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic LandscapesSemantic proximity Read ↗

Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scarsSemantic proximity Read ↗

Molecular dissection of abnormal wound healing processes resulting in keloid diseaseSemantic proximity Read ↗

HSFAS mediates fibroblast proliferation, migration, trans-differentiation and apoptosis in hypertrophic scars via interacting with ADAMTS8Semantic proximity Read ↗

Keloids – clinical diagnosis, pathogenesis, and treatment optionsSemantic proximity Read ↗

Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.Semantic proximity Read ↗

Extracorporeal Shock Wave Therapy Alters the Expression of Fibrosis-Related Molecules in Fibroblast Derived from Human Hypertrophic ScarSemantic proximity Read ↗

Keloid disorder: Fibroblast differentiation and gene expression profile in fibrotic skin diseasesSemantic proximity Read ↗

The secretome of irradiated peripheral mononuclear cells attenuates hypertrophic skin scarringSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.